Home LiteratureArticle Details
PMID: 22134167 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Blood ·Vol. 119 ·No. 3 ·2012-01-19 ·Pages 745-55

Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF

Abstract

Sema4D, also known as CD100, is a constitutively expressed immune semaphorin on T cells and NK cells. CD100 has important immune regulatory functions that improve antigen-specific priming by antigen-presenting cells, and can also act as a costimulatory molecule on T cells. We investigated the consequence of HIV-1 infection on CD100 expression by T cells, and whether CD100 expression signifies functionally competent effector cells. CD100 expression on T cells from healthy individuals was compared with HIV-1-infected subjects including elite controllers, noncontrollers, and patients receiving antiretroviral therapy. The frequency and fluorescence intensity of CD100 on CD8(+) and CD4(+) T cells were decreased during HIV-1 infection. Furthermore, the absolute number of CD100-expressing CD8(+) T cells was positively associated with the magnitude of HIV-1-specific T-cell responses. CD8(+) T cells lacking CD100 expression were functionally impaired and present in increased numbers in HIV-1-infected individuals. The number of CD100(-)CD8(+) T cells positively correlated with T-cell immunosenescence, immune activation, and viral load. Loss of CD100 expression appears to result from direct antigen stimulation, as in vitro cytokine exposure and viral replication did not significantly impact CD100 expression. These data suggest that loss of CD100 expression probably plays an important role in dysfunctional immunity in HIV-1 infection.

MeSH Terms
Antigen-Presenting Cells Antigens, CD Antiretroviral Therapy, Highly Active CD8-Positive T-Lymphocytes/immunology,metabolism,virology Case-Control Studies Cross-Sectional Studies Cytokines/metabolism Flow Cytometry HIV Infections/drug therapy,immunology,virology HIV-1/immunology Humans Lymphocyte Activation Semaphorins/deficiency Viral Load Virus Replication
Chemicals
Antigens, CD CD100 antigen Cytokines Semaphorins
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Eriksson Emily M
Division of Experimental Medicine, Department of Medicine, University of California–San Francisco, USA. erikssonemy@gmail.com
Milush Jeffrey M
Ho Emily L
Batista Mariana D
Holditch Sara J
Keh Chris E
Norris Philip J
Keating Sheila M
Deeks Steven G
Hunt Peter W
Martin Jeffrey N
Rosenberg Michael G
Hecht Frederick M
Nixon Douglas F
References (50)
50 references, click to expand
  1. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  2. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.
    J Immunol. 1992 Jan 15;148(2):318-23 PMID: 1530858
  3. Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.
    J Exp Med. 1984 Jun 1;159(6):1796-801 PMID: 6427385
  4. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
    Immunity. 2007 Sep;27(3):406-16 PMID: 17892849
  5. CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses.
    Cytokine Growth Factor Rev. 2003 Feb;14(1):17-24 PMID: 12485616
  6. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice.
    Immunity. 2000 Nov;13(5):633-42 PMID: 11114376
  7. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57.
    Hematol J. 2003;4(1):18-25 PMID: 12692516
  8. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis.
    J Immunol. 2001 Apr 1;166(7):4341-7 PMID: 11254687
  9. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
    Immunity. 2000 Nov;13(5):621-31 PMID: 11114375
  10. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells.
    J Immunol. 2002 Aug 1;169(3):1175-81 PMID: 12133937
  11. Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb.
    Int Immunol. 1995 Jan;7(1):1-8 PMID: 7718506
  12. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
    Eur J Immunol. 2001 Mar;31(3):677-86 PMID: 11241270
  13. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.
    Immunity. 2008 Dec 19;29(6):1009-21 PMID: 19062316
  14. SPICE: exploration and analysis of post-cytometric complex multivariate datasets.
    Cytometry A. 2011 Feb;79(2):167-74 PMID: 21265010
  15. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Nature. 2001 Mar 1;410(6824):106-11 PMID: 11242051
  16. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
    J Virol. 2009 Mar;83(6):2728-42 PMID: 19129459
  17. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.
    Blood. 2003 Mar 1;101(5):1962-9 PMID: 12406905
  18. Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.
    PLoS One. 2010 Jan 29;5(1):e8886 PMID: 20126452
  19. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.
    Blood. 2004 Aug 15;104(4):942-7 PMID: 15117761
  20. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses.
    Blood. 2001 Jun 1;97(11):3498-504 PMID: 11369643
  21. A novel role for the semaphorin Sema4D in the induction of allo-responses.
    Biol Blood Marrow Transplant. 2007 Nov;13(11):1294-1303 PMID: 17950916
  22. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
    Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14 PMID: 10694578
  23. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.
    J Infect Dis. 1999 Apr;179(4):859-70 PMID: 10068581
  24. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.
    J Exp Med. 2006 Oct 2;203(10):2281-92 PMID: 16954372
  25. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Nature. 2006 Sep 21;443(7109):350-4 PMID: 16921384
  26. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection.
    J Immunol. 2009 Jul 15;183(2):1120-32 PMID: 19564339
  27. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
    Nat Med. 2006 Oct;12(10):1198-202 PMID: 16917489
  28. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.
    Clin Infect Dis. 2005 Oct 1;41(7):1053-6 PMID: 16142675
  29. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.
    Cell. 1999 Oct 1;99(1):71-80 PMID: 10520995
  30. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1;18(4):332-40 PMID: 9704938
  31. Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    J Virol. 2003 Mar;77(5):3077-83 PMID: 12584333
  32. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.
    J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):346-55 PMID: 11917238
  33. High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals.
    J Immunol. 2006 Oct 15;177(8):5145-54 PMID: 17015699
  34. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
    J Virol. 2005 Nov;79(22):14169-78 PMID: 16254352
  35. The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase activity.
    J Biol Chem. 1997 Sep 19;272(38):23515-20 PMID: 9295286
  36. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
    J Exp Med. 1989 Apr 1;169(4):1421-34 PMID: 2784486
  37. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11780-5 PMID: 8876214
  38. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.
    Nat Med. 2002 Apr;8(4):379-85 PMID: 11927944
  39. CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion.
    J Immunol. 1996 Dec 15;157(12):5262-8 PMID: 8955171
  40. Apoptosis of CD57+ and CD57- lymphocytes in the lung and blood of HIV-infected subjects.
    Clin Immunol. 2005 Dec;117(3):294-301 PMID: 16290071
  41. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
    Blood. 2006 Jun 15;107(12):4781-9 PMID: 16467198
  42. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
    J Exp Med. 2000 Jul 3;192(1):63-75 PMID: 10880527
  43. Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP.
    Biochim Biophys Acta. 1996 Feb 2;1310(2):223-32 PMID: 8611637
  44. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
    PLoS One. 2010 Apr 21;5(4):e10249 PMID: 20422053
  45. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    J Virol. 2008 Jun;82(11):5398-407 PMID: 18353945
  46. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
    Blood. 2000 Nov 1;96(9):3094-101 PMID: 11049989
  47. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.
    Blood. 2003 Apr 1;101(7):2711-20 PMID: 12433688
  48. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  49. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
    Blood. 2005 Apr 15;105(8):3042-50 PMID: 15613544
  50. Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals.
    J Clin Immunol. 1986 Nov;6(6):502-9 PMID: 3097061
Article Info
Journal
Blood
Abbr.
Blood
ISSN
1528-0020
Published
2012-01-19
Epub
2011-00-01
Pages
745-55
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC3265199
Subset
IM
Grants
NIAID NIH HHS · AI68498 · United States
NIAID NIH HHS · AI 76 174 · United States
NHLBI NIH HHS · T32 HL007185 · United States
NIAID NIH HHS · K24AI069994 · United States
NIAID NIH HHS · K24 AI069994 · United States
NCRR NIH HHS · UL1 RR024131 · United States
NIAID NIH HHS · R01 AI087145 · United States
NIAID NIH HHS · P30 AI027763 · United States
NIAID NIH HHS · U01 AI034993 · United States
NIAID NIH HHS · R01 AI068498 · United States
NIAID NIH HHS · P30 AI27763 · United States
NIAID NIH HHS · U01-AI-034993 · United States
NIAID NIH HHS · T32 AI060530 · United States
NIAID NIH HHS · R24 AI067039 · United States
NHLBI NIH HHS · 5T32HL007185 · United States
NIAID NIH HHS · P30AI27763 · United States
NIAID NIH HHS · 2T32AI060530-06 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com